Management of Nerve Sheath Tumors Arising in the Sympathetic Chain

Surbhi Jain, MD; Kristin Houseknecht, MPH; Amyn M. Rojiani, MD, PhD; Matthias Setzer, MD; Frank D. Vrionis, MD, MPH, PhD

Disclosures

Cancer Control. 2008;15(4):352-357. 

In This Article

Study Limitations

This series comprises tumors in different locations that may cause different neurological deficits and functional impairment and may require different surgical techniques and approaches. However, all the tumors belong to the same histologic entity, having presumably the same biological behavior. Given that sympathetic schwannomas are rare, it seems to be justified to include cervical and thoracic tumors in one series.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....